Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

335
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Liver Physiology01:30

Liver Physiology

4.2K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

345
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in coronary disease severity at time of acute coronary syndrome between Middle East and North America.

Cardiovascular diagnosis and therapy·2026
Same author

Association of bidi smoking and tobacco-use patterns with cancer risk in India: a multicentre unmatched case-control study (2024-2025).

The Lancet regional health. Southeast Asia·2026
Same author

Incidental Radiation Exposure to the Internal Mammary Lymph Nodes in Breast Cancer Patients Undergoing Intensity-Modulated Radiation Therapy: A Retrospective Analysis.

The Gulf journal of oncology·2026
Same author

Actin dynamics: Filament end remodeling drives rapid depolymerization.

Current biology : CB·2026
Same author

To Intervene or Not to Intervene: Rethinking Non-culprit Vessels in Acute Coronary Syndrome.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Leiomodin 2 functions as a processive pointed-end elongator of actin filaments.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 30, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

31.1K

Liver disease in pregnancy.

Shashank Shekhar1, Gaurav Diddi2

  • 1Department of Obstetrics & Gynecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

Taiwanese Journal of Obstetrics & Gynecology
|November 3, 2015
PubMed
Summary

Liver dysfunction affects 3% of pregnancies, with pregnancy-related diseases being the most common cause. Differentiating these from incidental causes is crucial for proper management, often involving delivery.

Keywords:
HELLPLiver diseasescholestasis pregnancypregnancy

More Related Videos

Laparoscopic Left Liver Sectoriectomy of Caroli's Disease Limited to Segment II and III
04:41

Laparoscopic Left Liver Sectoriectomy of Caroli's Disease Limited to Segment II and III

Published on: February 27, 2009

14.7K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

3.4K

Related Experiment Videos

Last Updated: Mar 30, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

31.1K
Laparoscopic Left Liver Sectoriectomy of Caroli's Disease Limited to Segment II and III
04:41

Laparoscopic Left Liver Sectoriectomy of Caroli's Disease Limited to Segment II and III

Published on: February 27, 2009

14.7K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

3.4K

Area of Science:

  • Obstetrics and Gynecology
  • Hepatology
  • Maternal-Fetal Medicine

Background:

  • Liver dysfunction affects approximately 3% of pregnancies.
  • Causes are categorized as pregnancy-unique or incidental.
  • Pregnancy-related liver diseases are common and trimester-specific.

Purpose of the Study:

  • To provide an overview of liver dysfunction causes during pregnancy.
  • To update on the mechanisms of pregnancy-related liver diseases.
  • To outline diagnostic and management strategies for hepatic dysfunction in pregnancy.

Main Methods:

  • Literature review and synthesis of current knowledge.
  • Analysis of trimester-specific occurrence of liver diseases.
  • Methodological approach to diagnosis and management.

Main Results:

  • Pregnancy-related liver diseases are the primary cause of hepatic dysfunction.
  • Differentiating pregnancy-related from incidental causes is key for management.
  • Delivery is the cornerstone of management for most pregnancy-related liver conditions.

Conclusions:

  • Accurate diagnosis and management of liver dysfunction in pregnancy are essential.
  • Understanding trimester-specific presentations aids in timely intervention.
  • Effective management strategies improve maternal and fetal outcomes.